Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Mehmet Hilmi, Dogu"'
Autor:
Mehmet Hilmi Dogu, Ali Irfan Emre Tekgunduz, Burak Deveci, Gulten Korkmaz, Melda Comert, Ömür Gökmen Sevindik, Osman Yokus, Istemi Serin
Publikováno v:
HemaSphere, Vol 7, p e4210211 (2023)
Externí odkaz:
https://doaj.org/article/ee805a8f01364a2b99e3ea94f643282c
Autor:
Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Background: Gilteritinib (XOSPATA ®, Astellas) is a type I oral FLT3 inhibitor, a tyrosine kinase AXL inhibitor involved in both c-Kit and FMS-like tyrosine kinase 3 (FLT3) resistance. In the phase 3 ADMIRAL trial, gilteritinib was compared with the
Externí odkaz:
https://doaj.org/article/9f3497f7aa1a4fe6aa659432d98cdc66
Autor:
Istemi Serin, Nagehan Didem Sari, Mehmet Hilmi Dogu, Sakine Damla Acikel, Gulnıhal Babur, Avni Ulusoy, Mediha Irem Onar, Emre Cem Gokce, Oguz Altunok, Feyza Yaylaci Mert, Ayse Karakilic, Muhammed Baltik, Begum Gulesir
Publikováno v:
Journal of Infection and Public Health, Vol 13, Iss 11, Pp 1664-1670 (2020)
Background: COVID-19 (Coronavirus Disease-2019) is a pandemic disease, infecting more than 26.5 million people. Since there is no specific and effective treatment; early diagnosis and optimal isolation of the patient are of vital importance. Real-tim
Externí odkaz:
https://doaj.org/article/a56166bed2bc45eab194c4fcd2c49812
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-5 (2020)
Abstract Background Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma and may occur with lymph node and/or extranodal involvement. Recurrence in patients with diffuse large B-cell lymphoma usually occurs within the firs
Externí odkaz:
https://doaj.org/article/5ffbb72ce69345bd9f963e877d950f07
Autor:
Mehmet Bakırtaş, Mehmet Sinan Dal, Tuğçe Nur Yiğenoğlu, Asli Odabası Giden, Istemi Serin, Semih Başcı, Yasin Kalpakci, Serdal Korkmaz, Omer Ekinci, Murat Albayrak, Abdulkadir Basturk, Duzgun Ozatli, Mehmet Hilmi Dogu, Tuba Hacıbekiroglu, Merih Kızıl Çakar, Turgay Ulas, Mine Miskioglu, Emine Gulturk, Bulent Eser, Fevzi Altuntas
Publikováno v:
Journal of Chemotherapy. :1-7
Autor:
Istemi Serin, Mehmet Hilmi Dogu
Publikováno v:
Otolaryngology Case Reports, Vol 17, Iss , Pp 100246- (2020)
Solitary plasmacytoma accounts for 3–5% of all plasma cell diseases. Our case is about 55 years old male patient, who presented with isolated nasopharyngeal mass. He was consulted to Ear, Nose and Throat Diseases clinic by the Internal Medicine cli
Externí odkaz:
https://doaj.org/article/f980f32e080c4c9b847ba3c27e2be7df
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 1, Pp 30-34 (2016)
Introduction: Hepatitis B virus (HBV) infection is one of the most prominent health threats worldwide. Hepatitis B exacerbation is a significant cause of morbidity and mortality in patients who are the candidates of cytotoxic, immunosuppressive thera
Externí odkaz:
https://doaj.org/article/3222c5f302704706990a605f0f66360a
Autor:
Abdulkadir Karismaz, Mehmet Hilmi Dogu, Gülben Huq, Sermin Altindal, Osman Yokus1, Elif Suyani
Publikováno v:
The Pan African Medical Journal, Vol 31, Iss 125 (2018)
The prevalence of secondary cancers associated with the breast cancer treatment has increased, which is due to the administration of cytotoxic/hormonal drugs as well as radiotherapy. A 54-year-old female patient with a history of breast cancer for 4
Externí odkaz:
https://doaj.org/article/cdca8691b1cb487abbdf1d0ce047a799
Publikováno v:
İstanbul Medical Journal, Vol 22, Iss 4, Pp 245-249 (2021)
Introduction: Mucormycosis is an aggressive-progressive invasive fungal infection caused by mold fungi in the division of mucorales of the zygomycetes class with high mortality, and is the most common fungal infection in patients with hematologic mal
Autor:
Mehmet Ali Erkurt, Mustafa Mahir Ulgu, Tuba Hacibekiroglu, Serdal Korkmaz, Mehmet Sinan Dal, Osman Celik, Kursat Dal, Sinem Namdaroglu, Tuğçe Nur Yiğenoğlu, Suayip Birinci, Ilhami Berber, Naim Ata, Abdulkadir Basturk, Semih Başcı, Mehmet Hilmi Dogu, Burhan Turgut, Fevzi Altuntaş
Publikováno v:
Internal and Emergency Medicine
Previous studies reported that COVID-19 patients with cancer had higher rates of severe events such as intensive care unit (ICU) admission, mechanical ventilation (MV) assistance, and death during the COVID-19 course compared to the general populatio